Quarterly report pursuant to Section 13 or 15(d)

Common Shares, Warrants and Options (Details 3)

v3.23.1
Common Shares, Warrants and Options (Details 3) - USD ($)
 6 Months Ended 12 Months Ended
Feb. 28, 2023
Aug. 31, 2022
Common Shares, Warrants and Options    
Beginning Balance, Outstanding 424,836 206,170
Expired/Cancelled   (3,334)
Granted 49,600 222,000
Ending Balance, Outstanding 474,436 424,836
Ending Balance, Exercisable 446,936  
Weighted average exercise price, Beginning Balance, Outstanding $ 6.45 $ 8.90
Weighted average exercise price, Expired/Cancelled   9.60
Weighted average exercise price, Granted 2.11 4.21
Weighted average exercise price, Ending Balance, Outstanding $ 5.32 $ 6.45
Weighted Average Remaining Contractual Term, Outstanding (Years) 3 years 8 months 8 days  
Weighted Average Remaining Contractual Term, Granted (Years) 4 years 7 months 20 days  
Weighted Average Remaining Contractual Term, Ending (Years) 3 years 8 months 4 days  
Weighted Average Remaining Contractual Term, Exercisable (Years) 3 years 8 months 4 days  
Weighted average exercise price, Balance, Exercisable $ 5.38  
Aggregate intrinsic value, granted $ 55,748  
Aggregate Intrinsic Value, Exercisable 41,200  
Aggregate Intrinsic Value, Beginning $ 5,175  
Aggregate Intrinsic Value, Outstanding   $ 90,938